
THE 3’ END PROTHROMBIN GENE VARIANTS IN SERBIAN
PATIENTS WITH IDIOPATHIC THROMBOPHILIA Aradjanski M1, Djordjevic V1, Pruner I1,*, Tomic B1, Gvozdenov M1, Kovac M2,3, Radojkovic D1 *Corresponding Author: Dr. Iva Pruner, Institute of Molecular Genetics and Genetic Engineering, Vojvode Stepe
444A, PO Box 23, 11010 Belgrade, Serbia. Tel: +381-11-397-6658. Fax: +381-11-397-5808. E-mail: iva.pruner@
gmail.com page: 43
|
RESULTS
In this study, we included 100 patients with idiopathic
thrombophilia and 100 healthy controls. The
clinical data of the study group are shown in Table 1.
In our study, we detected the presence of A19911G
and C20068T variants in the 3’ end of the FII gene
(Figure 1).
In the patient group, there were 51.0% heterozygous
and 20.0% homozygous carriers of the A19911G
variant, which was similar to the frequency in the control
group (51.0% heterozygous and 19.0% homozygous)
(Table 2). The results of our study showed that
the difference between patients and controls was not
statistically significant (p = 0.88) and that A19911G
does not represent a risk factor for idiopathic thrombophilia
in our study (OR = 1.06; 95% CI 0.53-2.13).
Regarding this variant, both groups were in Hardy-
Weinberg equilibrium (c2 = 0.08; p = 0.77).
The C20068T variant was detected only in the
heterozygous state, with frequencies of 4.0% in patients
and 1.0% in the control group (Table 2). Even
though this difference between patients and controls
was not statistically significant (p = 0.21), it could
represent a risk factor in idiopathic thrombophilia
(OR = 4.12; 95% CI 0.45-37.52). The study groups
were in Hardy-Weinberg equilibrium for this variant
(c2 = 0.04; p = 0.83).
In our study, 4.0% of the patients were carriers
of both A19911G and C20068T mutations. This
subset of patients was distinguished by more severe
thrombotic manifestations. In one, DVT reoccurred
six times and three patients suffered from the combination
of more than two thrombotic events (MI,
DVT, PE, FL, and stroke).
|
|
|
|



 |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|
|